QA: Albireo Pharma INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001322505_2017_Albireo_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001322505, Albireo Pharma INC

  xvar xval
0 AssetsCurrent 30,861,000
1 IntangibleAssetsNetIncludingGoodwill 18,260,000
2 PropertyPlantAndEquipmentNet 21,000
3 remainder_Assets 518,000
4 LiabilitiesCurrent 12,708,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,372,491
9 ResearchAndDevelopmentExpense 8,482,241
10 remainder_Expenses -126,027
11 remainder_Revenues 56,708,996
12 remainder_NetIncome -2,277,834
13 remainder_ComprehensiveNetIncome 692,000
  yvar yval
0 Assets 49,660,000
1 Liabilities 12,708,000
2 Expenses 22,728,705
3 Revenues 56,708,996
4 StockholdersEquity 36,952,000
5 NetIncome 31,702,457
6 ComprehensiveNetIncome 32,048,457
7 BaseVar 72,387,768
8 EconomicCapitalRatiobeforeLimitedLiability 3.61
9 EconomicCapitalRatio 4.11

Edgar->Model Mapping

Feature Distribution

Change over Time